OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2021) Vol. 5, Iss. 3, pp. 872-888
Open Access | Times Cited: 387

Showing 26-50 of 387 citing articles:

Anticoagulation in Patients With COVID-19
Michael E. Farkouh, Gregg W. Stone, Anuradha Lala, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 9, pp. 917-928
Open Access | Times Cited: 51

Anticoagulants for people hospitalised with COVID-19
Ronald Luiz Gomes Flumignan, Vinicius Tassoni Civile, Jéssica Dantas de Sá Tinôco, et al.
Cochrane library (2022) Vol. 2022, Iss. 3
Open Access | Times Cited: 50

Clinical features of thrombosis and bleeding in COVID-19
Mari R. Thomas, Marie Scully
Blood (2022) Vol. 140, Iss. 3, pp. 184-195
Open Access | Times Cited: 41



Revista de Hematología (2024) Vol. 24, Iss. 3
Open Access | Times Cited: 7

Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial
María Marcos‐Jubilar, Francisco Carmona-Torre, Rosa Vidal, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 02, pp. 295-299
Open Access | Times Cited: 52

Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
Marijke Linschoten, Alicia Uijl, Astrid Schut, et al.
European Heart Journal (2021) Vol. 43, Iss. 11, pp. 1104-1120
Open Access | Times Cited: 49

COVID‐19–related laboratory coagulation findings
Katrien Devreese
International Journal of Laboratory Hematology (2021) Vol. 43, Iss. S1, pp. 36-42
Open Access | Times Cited: 46

Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia
Jean‐Louis Vincent, Marcel Levi, Beverley J. Hunt
The Lancet Respiratory Medicine (2021) Vol. 10, Iss. 2, pp. 214-220
Open Access | Times Cited: 44

Persistent Lung Injury and Prothrombotic State in Long COVID
Mengqi Xiang, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30

COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28

Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19
Margaret C. Fang, Kristi Reynolds, Grace H. Tabada, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232338-e232338
Open Access | Times Cited: 20

COVID-19 therapy and vaccination: a clinical narrative review
Siddharth Chinta, Miguel A Rodriguez Guerra, Mohammed Shaban, et al.
Drugs in Context (2023) Vol. 12, pp. 1-11
Open Access | Times Cited: 15

Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study
Alexander T. Cohen, Christopher Wallenhorst, Marcella Rivera, et al.
Thrombosis and Haemostasis (2024)
Open Access | Times Cited: 5

External Validation of the IMPROVE Risk Score for Predicting Bleeding in Hospitalized COVID-19 Patients
Yuzhi Tao, Feiya Xu, Jing Han, et al.
Journal of General Internal Medicine (2025)
Closed Access

Enoxaparin for thromboprophylaxis in hospitalized COVID‐19 patients: The X‐COVID‐19 Randomized Trial
Nuccia Morici, Gian Marco Podda, Simone Birocchi, et al.
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 5
Closed Access | Times Cited: 37

Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic
Natalia G. Vallianou, Dimitrios Tsilingiris, Gerasimos Socrates Christodoulatos, et al.
Metabolism Open (2021) Vol. 10, pp. 100096-100096
Open Access | Times Cited: 35

COVID‐19 and coagulopathy
Malay Sarkar, Irappa Madabhavi, Pham Nguyen Quy, et al.
The Clinical Respiratory Journal (2021) Vol. 15, Iss. 12, pp. 1259-1274
Open Access | Times Cited: 35

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
José Miguel Rivera‐Caravaca, Benjamin J. R. Buckley, Stephanie L. Harrison, et al.
Thrombosis Research (2021) Vol. 205, pp. 1-7
Open Access | Times Cited: 34

Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports
Konstantinos G. Kyriakoulis, Αναστάσιος Κόλλιας, Ioannis Kyriakoulis, et al.
Current Vascular Pharmacology (2021) Vol. 20, Iss. 1, pp. 96-110
Closed Access | Times Cited: 33

Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in Japan
Seiya Oba, Tadashi Hosoya, Miki Amamiya, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 32

International electronic health record-derived post-acute sequelae profiles of COVID-19 patients
Harrison G. Zhang, Arianna Dagliati, Zahra Shakeri Hossein Abad, et al.
npj Digital Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 24

Scroll to top